Clinical Trials Sponsored by Takeda Italia Farmaceutici S.p.A.

Total 7 results

Chiesi Italia

Active, not recruiting

Effects of Beclometasone Dipropionate/Formoterol Fumarate Via NEXT(Haler) in a Real-world Study on Asthma Control (NEWTON)

Asthma

Italy
Chiesi Italia

Completed

Global Burden and Treatment Trajectiories in Italian Patients With Fabry Disease (GROUND)

Fabry Disease

Italy
Chiesi Italia

Completed

Triple Therapy in Real-life: Impact on Adherence and Health Status (TRITRIAL)

COPD

Italy
Chiesi Italia
Gesellschaft für Therapieforschung mbH

Not yet recruiting

Observational Study on Therapy Pathways of Asthamics Treated With ICS/LABA/LAMA Therapy in a Real-world Setting (TRIMAXIMIZE)

Asthma
Istituto Clinico Humanitas
Fidia Farmaceutici s.p.a.; Ministero della Salute, Italy

Recruiting

Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg (PATTERN)

Osteoarthritis, Knee

Italy
San Carlo di Nancy Hospital
Lampugnani Farmaceutici S.p.A. (Nerviano, Milan, Italy)

Completed

Efficacy of Mictalase® After ThuLEP

BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms

Italy
Chiesi Farmaceutici S.p.A.
University of Pisa; Fondazione Don Carlo Gnocchi Onlus; Universita degli Studi... and other collaborators

Completed

Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

Italy

3

Subscribe